Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (9) , 1491-1495
- https://doi.org/10.1016/0006-2952(85)90689-6
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Effect of 1-alkyl-2-acetyl--glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the ratLife Sciences, 1984
- Specific receptor sites for 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranesBiochemistry, 1983
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- The metabolism of platelet activating factor in platelets and plasma of various animals.The Journal of Toxicological Sciences, 1983
- Response of mice and mouse platelets to acetyl glyceryl ether phosphorylcholineBiochemical and Biophysical Research Communications, 1982
- Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophilsBiochemical and Biophysical Research Communications, 1981
- Novel effects of 1-0-hexadecyl-2-acyl-sn-glycero-3-phosphorylcholine mediators on human leukocyte function: Delineation of the specific roles of the acyl substituentsBiochemical and Biophysical Research Communications, 1980
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949